Laurence Crowley Lecture Series - with Professor Joyce Tait
- Date: Monday, November 6, 2017
- Time: 5:30 PM - 7:00 PM
- Venue: UCD Smurfit School, E201
- Location: Carysfort Avenue, Blackrock, Co. Dublin
Advanced Innovative Biotechnologies:
a new approach to their regulation and governance
Regulation of biotechnology based industries includes many examples where well-meaning decisions have unintentionally stopped fruitful lines of innovation, have needlessly delayed the introduction of societally useful innovations and have prioritised incremental over disruptive innovation. There is a new understanding among governments and regulatory bodies that, in order to achieve the expected benefits from public investment in basic bio-science research, regulatory systems will need to become smarter and more adaptive and proportionate to the risks and benefits of innovative biotechnologies. However so far moves in this direction have been piecemeal and uncoordinated.
At this lecture, we welcome Professor Joyce Tait to discuss a new approach to achieving the necessary adaptation, involving the creative use of standards in a more equitable relationship with regulatory systems than they have had in the past.
7.00pm Closing remarks and reception
Biography, Prof. Joyce Tait, CBE, FRSE, D.Univ.(Open) Innogen Institute
Professor Joyce Tait has an interdisciplinary background linking natural and social sciences with particular interests in supporting development of advanced innovative technologies capable of delivering both economic and societal benefits. She has worked on: strategic planning for innovation; governance, risk management, regulation and standards; and stakeholder attitudes and influences. An important current project is exploring how standards could contribute to making governance systems more proportionate and adaptive to the needs of advanced innovative technologies. Innovation areas covered by this research include: GM, synthetic biology and gene editing; genetic databases; pharmaceuticals and antimicrobial resistance; cell therapies and regenerative medicine; diagnostic devices; FinTech; and stratified and translational medicine. Among current appointments are: UK Research Excellence Framework Interdisciplinary Research Advisory Panel; UK Department for Business, Energy and Industrial Strategy (BEIS) Synthetic Biology Leadership Council (and Chair of its Governance Subgroup); Scientific Advisory Board, John Innes Centre; and Governing Board of the Industrial Biotechnology Innovation Centre, University of Strathclyde.